OOIR: Observatory of International Research

Papers

(The H4-Index of Epilepsia is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
	711
PAC‐FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures	700
Targeting interictal low‐entropy zones during epilepsy surgery predicts successful outcomes in pediatric drug‐resistant epilepsy	349
Seizure outcomes in persons with autism spectrum disorder undergoing epilepsy surgery: A systematic review and meta‐analysis	270
Excitatory–inhibitory mismatch shapes node recruitment in an epileptic network	217
Comment on: Failure to use new breakthrough treatments for epilepsy	211
Optimizing pediatric status epilepticus management: The role of early midazolam infusion and adherence to clinical practice guidelines	188
The transcriptomic signature of DEPDC5 KO induced mTOR hyperactivation in human neurons and its re	173
Forty‐hertz sensory entrainment impedes kindling epileptogenesis and reduces amyloid pathology in an Alzheimer disease mouse model	134
Unmasking the role of the occipital lobe in epilepsy with eyelid myoclonia	130
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?	120
Impact of epilepsy on people experiencing homelessness: A mixed‐methods study	116
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures	109
Olig2‐specific loss‐of‐function Slc35a2 results in hypomyelination and spontaneous seizures	107
Cognitive stagnation and executive function deficits in young children with SCN1A + Dravet syndrom	106
Protective effect of CACNA1A deficiency in oligogenic refractory epilepsy with CACNA1A‐CELSR2 digenic mutations	103
Epilepsy treatment over time: The chess game analogy for choosing, adjusting, and adding antiseizure medications	103
Optimizing external validation of deep neural networks for interictal discharge detection	94
Surgical outcomes and motor function in pediatric peri‐Rolandic epilepsy: A single center's experience with 152 cases	90
Cytomegalic parvalbumin neurons in fetal cases of hemimegalencephaly	89
Reconsidering nonconvulsive status epilepticus diagnosis: 2.5‐Hz or etiology‐driven frequency cutoffs?	84
Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2‐related disorders	72
Response to Singh et al. 2023: It is premature for a unified hypothesis of sudden unexpected death in epilepsy: A great amount of research is still needed to understand the multisystem cascade	72
Role of cholesterol in modulating brain hyperexcitability	69
Sleep, oscillations, and epilepsy	67

Hippocampal sclerosis and temporal lobe epilepsy following febrile status epilepticus: The FEBSTAT study	66
Long‐term neuroplasticity in language networks after anterior temporal lobe resection	66
Scalp high‐frequency oscillation spatial distribution is consistent over consecutive nights, while rates vary with antiseizure medication changes	65
Anticonvulsive properties of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor	57
Neurocardiac pathologies associated with potassium channelopathies	56
Reasons for ineligibility for clinical trials of patients with medication‐resistant epilepsy	55
Screening for depression in patients with epilepsy: What are the benefits for physicians and patients in the real‐life setting	53
SCN8A self‐limited infantile epilepsy: Does epilepsy resolve?	52
Statistical learning in epilepsy: Behavioral and anatomical mechanisms in the human brain	52
Clinical effectiveness, feasibility, acceptability, and usability of mobile health applications for epilepsy: A systematic review	51
Extended follow‐up after anterior temporal lobectomy demonstrates seizure recurrence 20+ years postsurgery	50
Decision‐making in stereotactic epilepsy surgery	49
Prediction of long‐term unprovoked seizures after status epilepticus	48
Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach	47
Author index	46
Intracerebroventricular administration for delivery of antiseizure therapeutics: Challenges and opportunities	46
	45
Epilepsia – January 2023 – Announcements	45
No association between histopathology and neurophysiology in surgical specimens from pediatric focal epilepsy patients	44
The nuances of immunotherapy for NORSE/FIRES	44